Literature DB >> 2079229

Neoplasia-related changes of two copper (Cu)/zinc (Zn) proteins in the human colon.

T P Mulder1, H W Verspaget, A R Janssens, P A de Bruin, G Griffioen, C B Lamers.   

Abstract

Cu/Zn-containing proteins have recently become of interest with regard to their relation with malignant disorders. Cu Zn-superoxide dismutase (Cu/Zn-SOD) was found increased in chemically induced tumors of the large bowel whereas metallothionein (MT), containing Zn and some Cu, was shown important for the response of tumors to chemotherapy. In the present study, we evaluated the Cu/Zn-SOD and MT content of normal human colonic mucosa and colorectal carcinomas, obtained from 20 resection specimens, and of 47 adenomatous polyps. The Cu/Zn-SOD content of polyps and carcinomas was significantly (p less than 0.01) elevated when compared to normal mucosa. In the adenomatous polyps the Cu/Zn-SOD content increased significantly with increasing grade of epithelial cell dysplasia, diameter, and presence of a villous component. In the carcinomas no relation was noticed between the Cu/Zn-SOD content and the Dukes' stage or the grade of differentiation. The MT content was significantly decreased in both adenomatous polyps and carcinomas when compared to that in normal mucosa. The MT content was not related to the grade of epithelial cell dysplasia of the polyps, and to the Dukes' stage or the differentiation of the carcinomas. In conclusion, neoplasia of the colorectum is accompanied by an increase in Cu/Zn-SOD and a decrease in MT. These findings support the association between changes in Cu/Zn proteins and malignancy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079229     DOI: 10.1016/0891-5849(90)90128-6

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

1.  Prognostic evaluation of metallothionein expression in human colorectal neoplasms.

Authors:  E E Ioachim; A C Goussia; N J Agnantis; M Machera; E V Tsianos; A M Kappas
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

2.  Harnessing ROS-Induced Oxidative Stress for Halting Colorectal Cancer via Thiazolidinedione-Based SOD Inhibitors.

Authors:  Mohamed Nabil Abd Al Moaty; El Sayed H El Ashry; Laila Fathy Awad; Asmaa Mostafa; Marwa M Abu-Serie; Mohamed Teleb
Journal:  ACS Omega       Date:  2022-06-07

3.  Association of superoxide dismutase enzyme with staging and grade of differentiation colorectal cancer: A cross-sectional study.

Authors:  Budi Irawan; Ibrahim Labeda; Ronald Erasio Lusikooy; Samuel Sampetoding; M Ihwan Kusuma; Julianus Aboyaman Uwuratuw; Erwin Syarifuddin; Muhammad Faruk
Journal:  Ann Med Surg (Lond)       Date:  2020-09-02

4.  Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival.

Authors:  D Ofner; H Maier; B Riedmann; T Bammer; A Rumer; G Winde; W Böcker; B Jasani; K W Schmid
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients.

Authors:  A M J Langers; H W Verspaget; L J A C Hawinkels; F J G M Kubben; W van Duijn; J J van der Reijden; J C H Hardwick; D W Hommes; C F M Sier
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

6.  Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus.

Authors:  Y Hishikawa; T Koji; D K Dhar; S Kinugasa; M Yamaguchi; N Nagasue
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

7.  Superoxide dismutases in relation to the overall survival of colorectal cancer patients.

Authors:  A M Janssen; C B Bosman; C F Sier; G Griffioen; F J Kubben; C B Lamers; J H van Krieken; C J van de Velde; H W Verspaget
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

8.  SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression.

Authors:  R Tiwari; S K Pandey; S Goel; V Bhatia; S Shukla; X Jing; S M Dhanasekaran; B Ateeq
Journal:  Oncogenesis       Date:  2015-08-10       Impact factor: 7.485

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.